Helix Launches Whole Exome+® Sequencing for Patients with Rare and Unexplained Genetic Conditions

For patients with unexplained developmental delay, neurological conditions, and rare genetic disease, WES+ brings exome, mitochondrial, and chromosomal analysis together in a single order SAN MATEO, Calif., Sept. 10, 2026 /PRNewswire/ -- Helix, the leading enterprise genomics platform,...